A Prodrug Nanodevice Co-delivering Docetaxel and ROR1 siRNA for Enhanced Triple Negative Breast Cancer Therapy.
Yin L, Fu Z, Wang M, Liu B, Sun X, Liu K, Feng X, He Z, Wang Y, Hou J, Shao X, Yang N, Zhang T, Liu Y, Huang Z, Yin Q, Xie Y, Li Y, Lang T.
Yin L, et al. Among authors: he z.
Acta Biomater. 2024 Dec 25:S1742-7061(24)00776-1. doi: 10.1016/j.actbio.2024.12.055. Online ahead of print.
Acta Biomater. 2024.
PMID: 39730101